Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine

Known as: Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone-Etoposide Regimen, CHOPE regimen, VAC0P 
An abbreviation for a chemotherapy combination that is used to treat non-Hodgkin lymphoma. It includes the drugs cyclophosphamide, doxorubicin… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Self-replicating gene drives that modify sex ratios or infer a fitness cost could be used to control populations of invasive… Expand
2018
2018
Rationale: Cytokine release syndrome (CRS) is a common and potentially fatal complication of CAR-T cell therapy. However… Expand
2016
2016
Objectives: Optimal chemotherapy regimen for peripheral T-cell lymphomas (PTCL) has not been fully defined. This study aimed to… Expand
2015
2015
Myelosuppression is one of the most common side effects of chemotherapy. The aim of this study was to determine whether… Expand
2014
2014
We herein report the case of a 50-year-old woman who presented with persistent fever and a large mass in her right breast… Expand
  • table I
  • figure 1
  • figure 2
2011
2011
Abstract The aim of this study was to detail the physiological and biochemical changes in non-adulterated and commercially… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
2001
2001
To address the feasibility and outcome of moderate dose intensification with granulocyte‐colony stimulating factor (G‐CSF) for… Expand
2001
2001
Successful treatment of advanced-stage Hodgkin's disease (HD) may critically depend on dose intensity. Because mechlorethamine… Expand
2000
2000
Summary Background Patients with resistant diffuse aggressive non-Hodgkin's lymphoma (DA-NHL) have a poor prognosis. Studies have… Expand
2000
2000
BACKGROUND Patients with resistant diffuse aggressive non-Hodgkin's lymphoma (DA-NHL) have a poor prognosis. Studies have… Expand